NCT06299176View on ClinicalTrials.gov

Whole Heart Radiotherapy for End-stage Heart Failure

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Heart Failure NYHA Class IIIHeart Failure NYHA Class IVEnd-stage Heart FailureHeart Failure With Reduced Ejection Fraction
Interventions
OTHER

Whole Heart Radiation Therapy

Radiation to the whole heart in one treatment with a prescribed dose of 5 Gy.

Trial Locations (1)

H4A3J1

McGill University Health Centre, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT06299176 - Whole Heart Radiotherapy for End-stage Heart Failure | Biotech Hunter | Biotech Hunter